Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.68 | N/A | +1.32% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.68 | N/A | +1.32% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a cautious optimism about their performance. They acknowledged the competitive landscape but emphasized their commitment to growth.
Management expressed satisfaction with the EPS results despite not providing revenue figures.
They highlighted ongoing challenges in the retail environment but remain focused on strategic initiatives.
Prestige Consumer HE's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 2.19%, likely due to the lack of revenue details and overall market sentiment. Investors may be concerned about the company's future performance without clear guidance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Jul 30, 2018